Dominic D'Agostino

Dominic D'Agostino is a Professor of Molecular Pharmacology and Physiology at the University of South Florida. He received his Ph.D. in physiology from the University of Pittsburgh. He is a leading researcher in ketogenic diets and ketone supplements. He has conducted numerous studies on the medical use of ketogenic diets and ketone supplements for neurological and metabolic disorders, such as epilepsy, cancer, and diabetes.

Dr. D'Agostino's research has demonstrated that the ketogenic diet can be a safe and effective therapy for seizures, particularly in children who have not responded to other treatments. He has also shown that ketones can be beneficial in treating brain cancer and gliomas and may help slow the progression of Alzheimer's disease and Parkinson's disease.

In addition to his research, Dr. D'Agostino is a co-founder and scientific advisor of several companies developing ketone supplements and medical foods. He works closely with these companies to create new products and ensure they are safe and effective.

Dr. D'Agostino is also a sought-after speaker and has given numerous lectures and presentations on ketogenic diets and ketone supplements at conferences, universities, and other venues worldwide. He has also authored or co-authored several books and research papers.

Many organizations and publications have recognized Dr. D'Agostino's research. He has received several awards for his work, including the International Society for Nutritional Psychiatry Research (ISNPR) and the International Society for Nutritional Ketosis and Metabolism (ISNKT) awards. His work has also been featured in several popular media outlets, including Time Magazine, Forbes, The Huffington Post, and Business Insider.

Overall, Dr. Dominic D'Agostino has devoted his career to researching the benefits of ketogenic diets and ketone supplements, and he continues to be a leading expert in the field. His work has contributed significantly to understanding ketones' therapeutic potential. In addition, it has helped pave the way for new treatments for various neurological and metabolic disorders.